These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. What is breast cancer risk with Depo-Provera? Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459 [TBL] [Abstract][Full Text] [Related]
31. Are Norplant, Depo-Provera good options for nursing mothers? Contracept Technol Update; 1993 Mar; 14(3):46-8. PubMed ID: 12318085 [TBL] [Abstract][Full Text] [Related]
32. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. Harel Z; Biro FM; Kollar LM J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688 [TBL] [Abstract][Full Text] [Related]
33. Cyclofem shoots into injectable market. Family Plan World; 1992; ():19. PubMed ID: 12290896 [TBL] [Abstract][Full Text] [Related]
34. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686 [TBL] [Abstract][Full Text] [Related]
35. Depo-Provera: new developments in a decade-old controversy. Gold RB; Willson PD Fam Plann Perspect; 1981; 13(1):35-9. PubMed ID: 6452287 [TBL] [Abstract][Full Text] [Related]
36. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects. Basnayake S; Thapa S Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188 [TBL] [Abstract][Full Text] [Related]